News & Updates

Nephrolithiasis appears to be common among people with disabilities (PWDs), such that one in three people who have the kidney stone disease is a PWD, as reported in a study from the US.

The width of the spared neurovascular bundle (NVB) is an important indicator of postoperative sexual function after robot-assisted laparoscopic prostatectomy for prostate cancer, a recent study has found. These findings point to NVB as an easy intraoperative marker for assessing postoperative outcomes.

Triplet therapy combining androgen deprivation therapy (ADT), docetaxel, and abiraterone-prednisone improves overall survival (OS) in men with de novo metastatic castration-sensitive prostate cancer (mCSPC), according to results of the phase III PEACE-1 trial presented at ESMO 2021.

The prevalence of erectile dysfunction is significantly higher among men participating in in vitro fertilization (IVF) in order to conceive compared to couples who conceived spontaneously, reveals a recent study. Such occurrence leads to a very high rate of phosphodiesterase-5 inhibitor use.

In men with prostate cancer and concomitant atherosclerotic cardiovascular disease (ASCVD), major adverse cardiovascular event (MACE) incidence did not differ between those who were treated with degarelix or leuprolide, according to findings of the PRONOUNCE trial.

Treatment with leuprolide acetate every 6 months does not elicit significant changes in health-related quality of life (HRQOL) among prostate cancer (PC) patients despite substantial deterioration of body and role functions, a recent study has found.